Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AHCO NASDAQ:GRAL NYSE:TDOC NASDAQ:TOI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAHCOAdaptHealth$10.11+11.0%$9.05$7.11▼$11.70$1.23B1.581.04 million shs3.49 million shsGRALGRAIL$33.75+1.6%$41.29$12.33▼$63.99$1.20B3.261.01 million shs653,501 shsTDOCTeladoc Health$6.98+0.1%$7.71$6.35▼$15.21$1.23B1.767.74 million shs7.95 million shsTOIOncology Institute$3.96-1.7%$2.93$0.13▼$4.12$359.61M0.082.21 million shs2.18 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAHCOAdaptHealth+4.11%-5.01%+1.44%+2.76%-17.18%GRALGRAIL+1.34%-13.17%-29.02%+3.33%+100.30%TDOCTeladoc Health+0.58%-14.67%-15.24%+2.87%-12.20%TOIOncology Institute+8.04%+6.90%+63.49%+54.41%+647.82%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAHCOAdaptHealth3.767 of 5 stars3.51.00.00.01.51.74.4GRALGRAIL0.9613 of 5 stars1.14.00.00.01.10.81.3TDOCTeladoc Health3.4487 of 5 stars4.22.00.00.02.32.51.3TOIOncology Institute2.2904 of 5 stars3.72.00.00.03.60.80.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAHCOAdaptHealth 3.00Buy$13.4032.54% UpsideGRALGRAIL 2.25Hold$31.50-6.67% DownsideTDOCTeladoc Health 2.37Hold$9.7639.88% UpsideTOIOncology Institute 3.33Buy$7.0076.77% UpsideCurrent Analyst Ratings BreakdownLatest TOI, TDOC, AHCO, and GRAL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/25/2025TDOCTeladoc HealthMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$10.007/23/2025TOIOncology InstituteNoble FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$8.007/16/2025TOIOncology InstituteB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$6.007/15/2025TOIOncology InstituteB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy7/9/2025TDOCTeladoc HealthEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetIn-Line ➝ In-Line$7.00 ➝ $8.005/28/2025TDOCTeladoc HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$8.00 ➝ $7.005/27/2025TDOCTeladoc HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$10.00 ➝ $9.005/15/2025TOIOncology InstituteBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$7.005/14/2025GRALGRAILCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$32.00 ➝ $43.005/12/2025AHCOAdaptHealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$14.00 ➝ $13.005/8/2025AHCOAdaptHealthRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$14.00 ➝ $13.00(Data available from 8/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAHCOAdaptHealth$3.26B0.42$4.21 per share2.40$11.72 per share0.86GRALGRAIL$125.60M9.67$29.35 per share1.15$74.50 per share0.45TDOCTeladoc Health$2.57B0.48$5.58 per share1.25$8.05 per share0.87TOIOncology Institute$393.41M0.90N/AN/A$0.05 per share79.20Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAHCOAdaptHealth$90.42M$0.5717.7410.420.882.63%6.96%2.40%8/5/2025 (Estimated)GRALGRAIL-$2.03B-$60.990.00N/AN/A-1,464.53%-17.99%-15.02%8/12/2025 (Estimated)TDOCTeladoc Health-$1.00B-$1.19N/AN/AN/A-8.16%-10.13%-4.43%N/ATOIOncology Institute-$64.66M-$0.70N/A∞N/A-15.38%-445.02%-34.13%8/13/2025 (Estimated)Latest TOI, TDOC, AHCO, and GRAL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025TOIOncology Institute-$0.13N/AN/AN/A$112.56 millionN/A8/12/2025Q2 2025GRALGRAIL-$3.14N/AN/AN/A$37.57 millionN/A8/5/2025Q2 2025AHCOAdaptHealth$0.15-$0.03-$0.18$0.10$804.97 million$800.37 million7/29/2025Q2 2025TDOCTeladoc Health-$0.27-$0.19+$0.08-$0.19$621.91 million$631.90 million5/14/2025Q1 2025TOIOncology InstituteN/A-$0.18N/A-$0.21N/A$104.41 million5/13/2025Q1 2025GRALGRAIL-$4.03-$3.10+$0.93-$3.10$35.80 million$31.84 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAHCOAdaptHealthN/AN/AN/AN/AN/AGRALGRAILN/AN/AN/AN/AN/ATDOCTeladoc HealthN/AN/AN/AN/AN/ATOIOncology InstituteN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAHCOAdaptHealth1.251.291.07GRALGRAILN/A9.709.71TDOCTeladoc Health0.702.672.58TOIOncology Institute14.581.791.59Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAHCOAdaptHealth82.67%GRALGRAILN/ATDOCTeladoc Health76.82%TOIOncology Institute36.86%Insider OwnershipCompanyInsider OwnershipAHCOAdaptHealth1.55%GRALGRAILN/ATDOCTeladoc Health0.58%TOIOncology Institute8.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAHCOAdaptHealth10,500134.95 million132.86 millionOptionableGRALGRAIL1,36035.97 millionN/AOptionableTDOCTeladoc Health5,500176.69 million175.67 millionOptionableTOIOncology Institute66089.23 million81.65 millionNot OptionableTOI, TDOC, AHCO, and GRAL HeadlinesRecent News About These CompaniesCincinnati Insurance Co. Cuts Position in The Oncology Institute, Inc. (NASDAQ:TOI)July 31, 2025 | marketbeat.comWhat is Noble Financial's Forecast for TOI Q2 Earnings?July 29, 2025 | americanbankingnews.comWhat is Noble Financial's Estimate for TOI Q2 Earnings?July 28, 2025 | marketbeat.comThe Oncology Institute Announces Second Quarter 2025 Earnings Release Date and Conference CallJuly 25, 2025 | manilatimes.netMNoble Capital Gives Oncology Institute (TOI) Outperform RatingJuly 25, 2025 | insidermonkey.comNoble Financial Begins Coverage on Oncology Institute (NASDAQ:TOI)July 23, 2025 | marketbeat.comQ2 Earnings Estimate for TOI Issued By B. RileyJuly 18, 2025 | marketbeat.comThree weeks on, Kidwai’s sole MRI machine still not workingJuly 17, 2025 | timesofindia.indiatimes.comOncology Institute (NASDAQ:TOI) Raised to Strong-Buy at B. RileyJuly 17, 2025 | marketbeat.comB. Riley Securities Initiates Coverage of Oncology Institute (TOI) with Buy RecommendationJuly 17, 2025 | msn.comB. Riley Initiates Coverage on Oncology Institute (NASDAQ:TOI)July 16, 2025 | marketbeat.comTopicus.com Inc. Announces Release Date for Second Quarter ResultsJuly 14, 2025 | globenewswire.comThe Oncology Institute Names Kristin England as Chief Administrative OfficerJuly 14, 2025 | globenewswire.comThe Oncology Institute Becomes Exclusive Oncology Provider for 80,000+ SilverSummit Healthplan Medicaid MembersJuly 9, 2025 | finance.yahoo.comThe Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in NevadaJune 30, 2025 | globenewswire.comInvesting in Oncology Institute (NASDAQ:TOI) a year ago would have delivered you a 376% gainJune 29, 2025 | finance.yahoo.comA game-changer in cancer research? South Korean scientists reprogram tumour cells without chemotherapy or radiationJune 25, 2025 | msn.comTOI - The Oncology Institute Inc Sustainability - MorningstarJune 24, 2025 | morningstar.comMApprovals for oncology procedures rise under Ayushman Bharat Arogya Karnataka schemeJune 10, 2025 | timesofindia.indiatimes.comThe Oncology Institute, Inc. (NASDAQ:TOI) Director Sells $232,788.20 in StockJune 10, 2025 | insidertrades.comInsider Selling: The Oncology Institute, Inc. (NASDAQ:TOI) Director Sells 1,976,137 Shares of StockJune 6, 2025 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 2025View 3 Short Squeeze Candidates With Big Catalysts on the HorizonAmerica Wants Drone Dominance: Are These Stocks Ready to Soar?By Chris Markoch | July 20, 2025View America Wants Drone Dominance: Are These Stocks Ready to Soar?Super Micro Computer Sees Unusual Volume—Catalyst Ahead?By Gabriel Osorio-Mazilli | July 25, 2025View Super Micro Computer Sees Unusual Volume—Catalyst Ahead?This Drone Stock Is on Sale Despite Big Army ContractBy Jeffrey Neal Johnson | July 31, 2025View This Drone Stock Is on Sale Despite Big Army Contract3 Bullish Biotech Stocks With Explosive Growth TrendsBy Chris Markoch | July 21, 2025View 3 Bullish Biotech Stocks With Explosive Growth TrendsTOI, TDOC, AHCO, and GRAL Company DescriptionsAdaptHealth NASDAQ:AHCO$10.11 +1.00 (+10.98%) Closing price 04:00 PM EasternExtended Trading$10.12 +0.02 (+0.15%) As of 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.GRAIL NASDAQ:GRAL$33.75 +0.52 (+1.56%) Closing price 04:00 PM EasternExtended Trading$33.98 +0.23 (+0.68%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.Teladoc Health NYSE:TDOC$6.98 +0.01 (+0.14%) Closing price 03:59 PM EasternExtended Trading$6.94 -0.04 (-0.57%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.Oncology Institute NASDAQ:TOI$3.96 -0.07 (-1.74%) Closing price 04:00 PM EasternExtended Trading$3.97 +0.01 (+0.25%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Stock Soars After Blowout Earnings Report Vertical Aerospace's New Deal and Earnings De-Risk Production Zebra Technologies: Riding the Automation Wave to Profits Stop Overlooking Qualcomm—Here’s What the Market’s Missing Amazon Enters Correction Zone: Time to Panic or Be Brave? Figma's Wild IPO Ride: Is the Stock's Premium Price Justified? Applied Digital: Why a Surge in Bullish Bets Signals a New Era META Gets Huge Upgrades: How High Analysts Think Shares Could Go Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
